In a trade secret misappropriation case, the choice of remedy should not be left until the end of the proceedings. It may be the central question from the first day. If a competitor possesses confidential source code, customer data, internal pricing or a proprietary manufacturing process, a damages award several years later may arrive after the commercial advantage has already been lost.
For foreign businesses and overseas counsel considering proceedings in Israel, litigation strategy should therefore begin with what the court needs to do in practical terms. Is it necessary to stop the use or further disclosure of information immediately? Preserve or seize evidence before it disappears? Obtain accounts of the defendant’s activities? Recover financial losses? Or ensure that the proceedings themselves do not expose the very information the claimant seeks to protect?
Every remedy must be connected to the particular violation. The starting point is to identify the trade secret and the alleged misappropriation, as explained in Trade Secret Misappropriation in Israel: Taking, Use and Disclosure.
An injunction may be the most important remedy
Much of a trade secret’s value lies in the fact that competitors do not possess the information. Where misappropriation is ongoing, the owner’s immediate objective will often be to stop use of the secret or prevent it from being disclosed further.
An injunction may prohibit the use of the secret, its transfer to third parties or its disclosure to additional employees or suppliers. Depending on the circumstances, relief may also require steps to end the violation, such as deleting copied files or stopping the use of an unlawfully obtained database.
The injunction must not give the claimant protection broader than the underlying right. If the protected material is a particular database, the court should not turn that protection into a general prohibition on competing with the database owner. If only part of the disclosed information is confidential, the order should focus on that information.
In L.D.B. Global Investments Ltd. v. Tera Capital Real Estate and Finance Investment House Ltd., Tel Aviv District Court, Civil Case 4407-09-25 (30 October 2025), the court granted interim relief concerning four identified lists that appeared to contain distinctive business information. It did not prohibit the respondents from competing by using information or identifying customers independently.
An application for an injunction must identify the secret
A common problem with requests for injunctive relief is language such as “all of the company’s business information” or “all its trade secrets.” Such wording makes it difficult for the court to determine precisely what conduct is to be prohibited, or for the defendant to understand what would constitute a breach of the order.
In Electra v. Wawi, Central District Court, Civil Case 24242-03-18 (15 July 2018), the court emphasized that interim relief must address identifiable items of information and be capable of expression in an enforceable order.
This is more than a drafting formality. The broader the proposed injunction, the greater the risk of restricting lawful competition alongside the allegedly unlawful use. A claimant should identify, as precisely as circumstances permit, the relevant files, data, processes, lists or categories of information.
Interim injunctions are sought before rights have been finally determined
An application for interim relief is made before the court has finally decided whether a protected trade secret exists or has been misappropriated. Rule 95 of Israel’s Civil Procedure Regulations, 5779-2018, requires sufficient prima facie evidence of the cause of action, satisfaction of the applicable requirements and a demonstrated need for interim relief.
The court also weighs the harm likely to result to the applicant if relief is refused against the harm to the respondent if it is granted. It considers possible harm to third parties or the public interest, whether a less restrictive remedy would achieve the same purpose, the parties’ good faith and whether the applicant delayed excessively in bringing the claim or the application.
These considerations are particularly important in trade secret cases. Preventing use of confidential information may be essential to protecting its value, but an excessively broad order may halt a product launch, business activity or an employee’s move to a new employer before the dispute has been adjudicated.
Delay may undermine a request for urgent protection. A company that discovers suspected misuse but waits months before applying to court may struggle to establish immediate necessity. Delay is not, however, a substitute for assessing the actual harm and circumstances at the time of the application.
In employment disputes, an injunction protecting specific information should not automatically become a general prohibition on working in the employee’s profession. See Employee Trade Secrets in Israel: Confidentiality, Loyalty and Non-Compete Clauses.
An injunction can be limited in time
An order prohibiting use of a trade secret is not necessarily permanent. Trade secret protection continues only while the information remains confidential and meets the requirements of the law.
Section 14 of the Commercial Torts Law, 5759-1999, establishes a mechanism for reviewing an injunction once the secret has become public. Even after disclosure, however, the court may maintain the injunction if the defendant gained an unfair advantage from possessing the secret before it became public, for as long as that advantage persists.
The rule reflects the special nature of trade secrets. Misappropriation may have spared a competitor years of research, customer development or market entry. Subsequent publication of the information does not necessarily erase the time advantage already obtained.
Damages for loss suffered by the trade secret owner
Where loss can be established, the owner may seek damages caused by the misappropriation. The loss may involve reduced sales, lost customers, price erosion, expenditure occasioned by the violation, the loss of a competitive advantage or a reduction in the value of the secret.
Proving causation and quantifying the loss can be difficult. Falling revenue may also result from lawful competition, market changes or other factors. Even where unauthorized use is established, it may be hard to show which particular contracts were lost because of that use and what profit the claimant would otherwise have earned.
This difficulty is one reason Israeli law provides an alternative form of compensation without proof of the amount of actual damage.
Statutory damages of up to NIS 100,000 per tort without proof of actual damage
Under Section 13 of the Commercial Torts Law, the court may, at the plaintiff’s request, award up to NIS 100,000 for each tort without proof of the amount of damage suffered.
That does not mean every access to a file or every transfer of a document automatically gives rise to a separate award. Section 13(b) treats torts committed as part of a single course of acts as one tort for this purpose. Conversely, where separate trade secrets and distinct violations are established, the characterization and number of torts can have substantial financial consequences.
In Korea Motors Israel Ltd. v. Avraham Ungar, Tel Aviv District Court, Civil Case 2262/08 (10 March 2021), the District Court identified 25 trade secrets misappropriated through unauthorized computer access and awarded a total of NIS 2,500,000 in statutory damages. It also ordered that use of the materials cease and that they be destroyed. The case subsequently became the subject of appellate proceedings, which should be considered when assessing its current procedural and precedential position.
Seeking statutory damages does not make the scope of the misconduct irrelevant. The nature of the secrets, the manner of acquisition, the extent of use, the number of distinct secrets and the relationship between the acts may affect both the number of torts and the amount awarded within the statutory limit.
Restitution focuses on the defendant’s gain
Damages and restitution examine the same conduct from different perspectives. Damages aim to compensate the trade secret owner for loss. Restitution concerns the benefit the defendant obtained unlawfully.
Using confidential information may save a competitor substantial research, development, customer acquisition or market-entry costs. In other cases it may generate sales or new customer relationships. Depending on the circumstances, a claim under trade secret law may be accompanied by a restitutionary claim under Israel’s law of unjust enrichment.
In Strauss Water Ltd. v. Netanel Shmuel Malka, Central District Court, Civil Case 34442-03-20 (4 February 2022), the court accepted an unjust enrichment claim alongside the trade secret misappropriation claim arising from use of customer information for competing business activity. A permanent injunction was granted, while the monetary relief remained to be determined.
The same economic harm or gain should not be recovered twice. A claimant may advance alternative methods of calculation, but the ultimate award must reflect the loss or enrichment without double recovery for the same consequence.
An account of profits or dealings may help quantify financial relief
The trade secret owner may not know how many transactions the defendant completed using the information, which customers moved to the defendant or how much income resulted from the misuse. Such evidence will frequently be in the defendant’s possession.
Section 15 of the Commercial Torts Law allows the court to require the defendant to render an account concerning the particulars of the tort. Where appropriate, this procedure can provide data needed to calculate monetary relief.
It is therefore not always necessary to choose at the outset between an injunction and compensation. A claim may seek to stop the violation, establish its scale through the defendant’s records and then quantify its financial effect.
Preserving evidence where there is a risk of concealment or destruction
The Commercial Torts Law also provides procedures designed to preserve evidence. Section 16 and the related provisions permit the court, under the statutory conditions, to appoint a receiver authorized to search for and seize relevant assets or evidence. This may be available where there is a real suspicion of a tort and a reasonable suspicion that evidence may be concealed.
Such relief is exceptional and intrusive. In appropriate circumstances it may be ordered ex parte, where prior notice could frustrate its purpose, subject to security requirements and procedural safeguards protecting the respondent and affected third parties.
The practical significance may be considerable in cases involving copied digital information. Files can be deleted, computers replaced and access records altered. In the Strauss Water litigation, an early seizure order was issued, and material gathered during its execution became significant evidence in the ensuing proceedings.
Protecting a trade secret during litigation may require limited disclosure
A claimant must identify the alleged secret and show what was taken or used. This creates an inherent problem: the litigation itself may risk revealing the information the claimant seeks to protect.
Israeli law does not resolve that problem by relieving the claimant of its burden of proof. Instead, it authorizes the court to regulate the proceedings so that necessary information is disclosed only to the extent required.
Section 23 of the Commercial Torts Law empowers the court to prevent publication of a trade secret revealed in proceedings, regulate the manner in which evidence containing a trade secret is presented, and, in appropriate civil proceedings, order that particular evidence not be disclosed.
Complete non-disclosure is the more exceptional measure. In civil proceedings, it requires the court to conclude that the interest in withholding the evidence outweighs the need for its disclosure in the administration of justice and that less restrictive protection would be insufficient.
Depending on the case, narrower mechanisms may include restricting access to documents, redacting unnecessary portions, limiting use of information to the litigation, controlling the submission of expert evidence, prohibiting publication and, where justified, hearing part of the proceedings in closed court. Israeli decisions examining such questions include Vitelson v. Pentacom, Bitum v. Chemiprene, Rami Levy v. Dahan and Israel Aerospace Industries v. Dekel.
Trade secret protection can justify closed court proceedings
Section 68(b)(8) of the Courts Law [Consolidated Version], 5744-1984, permits proceedings to be heard behind closed doors where necessary to protect a trade secret.
In Delek Motors Ltd. v. State of Israel, Supreme Court, Civil Leave to Appeal 8362/17 (4 January 2018), the Court considered the protection of confidential commercial agreements, discounts, customer data and business correspondence. Such information may justify restricting the public nature of proceedings where disclosure would prejudice a legitimate confidential commercial interest.
Merely asserting that information is a trade secret does not automatically close a courtroom. The party seeking protection must identify the information and explain the harm likely to arise from its disclosure. The court may confine protection to specified documents or only part of a hearing.
Relief must be tailored to the secret and the violation
An effective misappropriation claim should not begin and end with a general demand to “stop the infringement and award damages.” The particular secret, the conduct concerning it and the remedy necessary to address that conduct must be connected.
Where use is continuing, an injunction may be paramount. Where evidence may disappear, urgent preservation or seizure may be necessary. If the violation has ended but a quantifiable loss remains, the focus may shift to damages. If the defendant obtained an economic benefit that cannot readily be measured through the claimant’s loss, restitution and an account of the defendant’s dealings may become important. And if the case cannot be proved without referring to the confidential information itself, protective measures within the proceedings should be planned from the outset.
In trade secret litigation in Israel, the remedy is not merely the final outcome. Sometimes it determines whether, when the litigation ends, there is still a secret worth protecting.
